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Abstract
Oncoplastic breast conserving surgery is the gold 
standard approach for the surgical treatment of early 
breast cancer. There is a well defined technique named 
“therapeutic mammoplasty” which is characterized for 
using a reduction mammaplasty technique to treat 
breast cancer conservatively. In our current practice, 
“therapeutic mammoplasty” or therapeutic reduction 
mammaplasty is our favorite oncoplastic breast 
conserving approach which it used in almost half of 
our patients. This technique is very versatile allows us 
the resection of tumors located in all breast quadrants 
of patients with moderate-to large-sized breasts. We 
describe a series of 57 patients who were treated using 
a therapeutic reduction mammaplasty. All surgical 
procedures were carried out by one comprehensive 
breast surgeon who planned and designed the surgery 
performing both oncologic and reconstructive procedures. 
Surgical margins were insufficient in eight patients 
(14%). Nine patients (15.8%) had a complication in 
early postoperative period and in one of them adjuvant 
radiotherapy was delayed four months due to a wound 
dehiscence. The rate of synchronous contralateral 
symmetrization was 31.6%. Our conclusion is that 
reduction mammaplasty is a useful and safe skill to treat 
breast cancer conservatively playing a very important role 
therefore it must be situated in the priority of learning 
objectives.
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Core tip: Reduction mammaplasty techniques are 
a really useful and safe skills to treat breast cancer 
conservatively allowing breast surgeons manage tumors 
located in all breast quadrants with low morbidity 
in moderate to large breasted patients, thanks their 
versatility they play a very important role in oncoplastic 
conservative surgery therefore they must be situated in 
the priority of learning objectives.
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INTRODUCTION
Currently, oncoplastic breast conserving surgery (OBCS) 
should be the gold standard approach for the surgical 
treatment of early breast cancer[1-3]. Oncoplastic 
techniques (OT) offer clear advantages on nearly forty 
percent of patients in who common breast conserving 
treatment (BCT) (surgery plus radiotherapy) are 
followed by cosmetic sequelaes[4] besides the rest of 
the patients who also could be benefited from many 
surgical tricks which can improve aesthetic outcomes[5]. 
Since 1998, when Audretsch et al[6] described the use of 
plastic surgery techniques to reshape the breast at the 
time of lumpectomy or quadrantectomy introducing the 
term “oncoplastic”, it has passed enough time to be able 
to evaluate long-term oncologic outcomes, therefore a 
meta-analysis gathering 3165 patients treated by OBCS 
vs 5494 treated BCT have demonstrated that OBCS 
obtain similar results to standard breast conserving 
surgery improving cosmetic outcome and patients’ 
satisfaction[7].
There is a large amount of OT but these can be 
classified in two main groups: Volume replacement or dis­
placement techniques. Nowadays, the last ones, which 
are more frequently used[8], have a broad technical 
variety with different patters incisions, pedicles used for 
nipple areola complex (NAC) movement, ways to fill 
tumor removal defect and their multiple combinations. 
Several authors[9-13] have created different algorithms 
attempting to optimize OT and offering us a method 
to select the most appropriate OT in each patient. 
These algorithms for immediate conservative surgery 
reconstruction are based on some aspects such as type 
and size of the breast, extent of tumor removal defect, 
ptosis degree, breast tissue density and location of the 
tumor in the breast. Other aspects very important in the 
process of decision are patient preferences and surgeon 
expertise. 
In OT displacement volume group there is well 
defined technique a “therapeutic mammoplasty” term 
coined by McCulley et al[14,15] which is characterized 
for using a reduction mammaplasty technique and 
radiotherapy to treat breast cancer. These authors 
described two different scenarios depending if the 
tumor lies or not within the routine pattern incision and 
excision dividing the breast in nine areas with theirs 
corresponding approaches. Therapeutic mammaplasty 
is especially useful in large breasted patients in who a 
bilateral reduction mammaplasty offers clear advantages 
which are both oncological and functional which cause 
better radiation therapy and beside relieving the symp-
toms related to breast hypertrophy thus improves 
quality of life[16], even more, this approach is a better 
option than skin-sparing total mastectomy and imme-
diate reconstruction having lower morbidity and more 
favorable cosmesis[17]. 
Munhoz et al[18], wrote that the main advantages of 
the therapeutic reduction mammaplasty (TRM) should 
include reproducibility, low interference with oncological 
treatment and long-term results. We agree completely 
with him and it is more, based on our experience, we 
would like to add that this technique is versatile because 
it could be used to treat tumors located in all breast 
quadrants with the condition that the patient having a 
moderate to large-sized breast.
The aim of this work was to communicate our 
experience with TRM showing the distribution of tumors 
into the breast, rate of affected margins, early surgical 
complications, and synchronous contralateral breast 
symmetrization.
PATIENTS AND METHODS
Between 2005 and 2013, 57 patients suffering from 
breast cancer suitable for BCT underwent TRM at our 
Oncoplastic Breast Unit, Hospital Valdecilla (Santander, 
Spain). All surgical procedures were carried out by one 
comprehensive breast surgeon (FH) who planned and 
designed the surgery performing both oncologic and 
reconstructive procedures. Data from patient and tumor 
characteristics, surgical procedures, early complications 
and pathological study were prospectively collected and 
stored in IBM SPSS statistics program.
RESEARCH RESULT
Characteristic of patients and tumours are described 
in Tables 1 and 2. Seven patients were treated before 
surgery with neoadjuvant chemotherapy. Most of 
tumor excisions were guided by needle-wires (84.2%) 
according to our method previously published[19]; wires 
were inserted 1 cm distant to radiologic tumors limits as 
markers of optimal limit resection, sufficiently of resection 
margins was per-operatively tested by X-ray analysis 
of surgical specimen. Biopsy of sentinel lymph node 
(49) and axillary linfadenectomy (10) was performed 
in mostly patients by the T inverted pattern incision. 
Opposite breast surgery by reduction mammaplasty was 
carried out in eighteen patients (31.6%). 
Surgical margins status
Margins were insufficient in eight patients (14%), five 
affected and three with focal involvement. Two of them 
having affected margins underwent total mastectomy. 
Pathologic study of mastectomy showed residual 
invasive carcinoma and carcinoma in situ in one patient 
and residual ductal carcinoma in situ in the other.
Early surgical complications
Nine patients (15.8%) had a complication in early 
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postoperative period (five a hematoma, four a minor 
wound dehiscence) and three of them had to be re-
operated for evacuating a hematoma. There were no 
major complications such necrosis of NAC or severe 
breast infections and only one adjuvant radiotherapy 
was delayed four months in one patient due to a wound 
dehiscence. 
DISCUSSION
Although some OT are specifically useful to manage 
some determined tumor locations such as a lateral 
or tennis racket mammaplasty[20] for tumors located 
at upper outer quadrant or LIQ­V mammaplasties[21] 
for these located at lower inner quadrants, reduction 
mammaplasty with T inverted pattern incision appro-
priately adapted is be able to treat tumors situated 
at all breast quadrants. In a very large series of 540 
consecutive cases published by Fitoussi et al[22] in which 
a variety of OT were used, T inverted pattern incision 
was the most frequently utilized in 40% of patients. Our 
current BCT entails 77.2% of breast cancer surgery and 
in oncoplatic breast conserving experience using volume 
displacement technique this pattern incision is the most 
common (Figure 1) used in 52% of cases, and our 
favorite approach (unpublished data). 
As inner quadrants were the less frequent tumor 
localizations with 10.6% and the outer ones were the 
most frequent our first choice to move NAC was a 
superomedial pedicle but in this series we also used 
inferior and bipedicled ones. In those patients with central 
tumors in who NAC had to be removed we reconstructed 
NAC using different techniques, for example, contralateral 
areola (Figure 2) or skin graft plus arrow flap for nipple 
reconstruction. The variation of localizations shows the 
versatility of TRM in breast with moderate or large size.
Early complications rate was 15.8%, these were 
minor; our experience is similar to others authors 
such as Gulcelik et al[23] who reported a rate of minor 
early complications of 16.3% and major ones of 1.9% 
without differences between reduction mammaplasy 
used for macromastia treatment and breast cancer. 
A wide range of complications rate of therapeutic 
reduction mammaplasty has been reported[24] likely due 
to differences in criteria and collecting data but, one 
conclusion is uniform that they usually are minor not 
impacting seriously on delivery of adjuvant therapies 
unless they were severe, McIntosh et al[25] in a systematic 
review found that delayed adjuvant treatment in only 6% 
of cases.
The rate of synchronous contralateral symmetrization 
was 31.6% but most of these patients were operated in 
the first half of the series before 2011; like as Fitoussi 
et al[22] our current preference is delayed contralateral 
symmetrization. The reasons for that have been clearly 
exposed by Kaviani et al[26] who categorized the patients 
in three groups: Patients unwilling any contralateral 
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Table 1  Characteristics of the series of 57 patients  n  (%)







Tumour location through the breast (quadrant)
Upper outer 16 (28.1)
Upper inner 3 (5.3)
Lower Inner 3 (5.3)
Central 12 (21.1)
Intersection upper quadrants   7 (12.3)
Intersection lower quadrants 5 (8.8)
Intersection inner quadrants 3 (5.3)
Intersection outer quadrants   7 (12.3)
Inframmary fold 1 (1.8)
Multifocal  14 (24.6)
Radiological tumour size (mm) 21.7, 12.58 SD
Table 2  Characteristic of 57 breast carcinomas  n  (%)
In situ      7 (12.3)
Invasive    50 (87.7)
Type of histology 
Ductal        39
Lobular          6
Mixed          1
Papilar          1
Others          3
Positive estrogenic receptors        38
Positive progesterone receptors        37
Positive Herb2 receptors          7
Ki67 (n = 42)
> 10%        15
10%-50%        19
51%-75%          3
> 75%          4
Pathologic tumour size (mm) 17.1, 9.77 SD













Figure 1  Distribution of the pattern incisions used in breast cancer patients 
treated using oncoplastic conservative approach at our unit.
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marized by the fact that almost none patients regretted 
to chose this type of surgery[18]. Changes of aesthetic 
outcomes over the time after completing radiotherapy 
have been commented not affecting negatively patient 
satisfaction. In our experience, TRM as reduction 
mammaplasty technique has the same limitations and 
aesthetic outcomes can be deteriorated over the time by 
pseudoptosis (Figure 4) or excessive weight gain. 
Finally, all OT and more specifically those of level Ⅱ 
are based on the knowledge of reduction mammaplasty 
techniques; independently, which model for oncoplastic 
approach can be chosen “comprehensive breast 
surgeon” or “oncologic and plastic team”, skill sharing 
procedures, patients preferring an all-in-one operation 
willing immediate symmetrization and patients desiring 
optimal aesthetic results; only patients belonging to the 
second group are candidates to immediate contralateral 
symmetization. In our experience, our average patient 
is in the first group. Figure 3 shows the appearance 
of a patient belonging to third group with breast asym-
metry which she wants it to be corrected; we will 
carry out symmetrization of the right breast when she 
stabilized her weight because she put on weight during 
chemotherapy treatment. 
Patient satisfaction and aesthetic outcomes reported 
are very high with a low rate of failure as which sum-
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Figure 2  A 40-year-old postmenopausal woman with an invasive ductal carcinoma with positive estrogenic, progesterone and Herb2 receptors situated at 
central quadrant of right breast which sized 15 mm on mammograms. A and B: Appearance of patient. Design of pattern of therapeutic reduction mammaplasty; 
C and D: Nipple areola complex right reconstructed by contralateral areola graft. Long-term aesthetic outcome.
A B
C D
Figure 3  Appearance of a 49-year-old woman after underwent oncoplastic breast conserving surgery and posterior adjuvant chemotherapy and 
radiotherapy. She had a bifocal invasive lobulillar carcinoma situated at intersection of upper quadrants with positive estrogenic and progesterone receptors and 
T2N0M0 pathological staging. She presents breast asymmetry which she wants it to be corrected.
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between breast unit members is eagerly desirable and, 
in our opinion, about reduction mammaplasty techniques 
the former statement is essential. Accepting the lack of 
oncoplastic training[27] and the fact that expertise requires 
long time[28], we proposed a management policy[29] to 
mitigate this situation incorporating the surgical treat-
ment of symptomatic macromastia into Breast Cancer 
Unit[30]. One step in this direction is the inclusion of 
gynaecomastia and congenital asymmetry surgical 
treatment into several Oncoplastic Breast Surgery Units 
in United Kingdom.
CONCLUSION
Reduction mammaplasty technique is a useful and 
safe skill to treat breast cancer located in all breast 
quadrants with low morbidity playing a very important 
role in oncoplastic conservative surgery in moderate to 
large breasted patients therefore it must be situated in 
the priority of learning objectives.
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